Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia

Clinical trial NCT03573700 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03573700
Sponsor: St. Jude Children's Research Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia, in Relapse Acute Lymphoblastic Leukemia, Refractory

Start date: 2018-07-24
Primary completion: 2023-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.